NIAID News Release: Media Availability: Weakened Malaria Parasites Form Basis of New Vaccine Strategy
Tuesday, September 27th, 2011WHAT: Using live but weakened malaria parasites as the basis of a vaccine represents a potentially encouraging anti-malaria strategy, according to results of follow-up animal studies performed after the conclusion of a recent clinical trial in humans. The research was conducted by scientists at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, working in concert with a large team of collaborators. The findings were published online September 8 in Science Express.
The parasite that causes malaria, a disease that kills nearly one million people each year, is transmitted to humans via the bite of an infected mosquito.
